Marker Therapeutics (MRKR) Other Non-Current Assets (2010 - 2022)
Marker Therapeutics (MRKR) reported Other Non-Current Assets of $17.8 million for Q4 2022, up 1518.45% year-over-year from $1.1 million in Q4 2021, and up 8801.46% quarter-over-quarter from $200000.0 in Q1 2022.
Marker Therapeutics (MRKR) Other Non-Current Assets (2010 - 2022) Analysis & Trends
Marker Therapeutics (MRKR) has 8 years of Other Non-Current Assets data on file, last reported at $17.8 million in Q4 2022.
- Other Non-Current Assets for Q4 2022 came in at $17.8 million, up 1518.45% year-over-year; the trailing twelve-month figure through Dec 2022 was $17.8 million (up 1518.45% YoY), and the FY2022 annual result was $17.8 million, up 1518.45% from the prior year.
- Other Non-Current Assets grew to $17.8 million in Q4 2022 per MRKR's latest filing, from $200000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $17.8 million in Q4 2022 and troughed at $200000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 17.80 Mn |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Dec 31, 2015 | 68,803.00 |
| Sep 30, 2015 | 138,286.00 |
| Jun 30, 2015 | 142,590.00 |
| Mar 31, 2015 | 82,504.00 |
| Dec 31, 2014 | 82,504.00 |
| Mar 31, 2014 | 747.00 |
| Dec 31, 2013 | 13,439.00 |
| Sep 30, 2013 | 118,954.00 |
| Mar 31, 2013 | 118,954.00 |
| Dec 31, 2012 | 15,004.00 |
| Sep 30, 2012 | 12,641.00 |
| Jun 30, 2012 | 24,637.00 |
| Mar 31, 2012 | 28,464.00 |
| Dec 31, 2011 | 32,291.00 |
| Sep 30, 2011 | 36,160.00 |
| Jun 30, 2011 | 40,029.00 |
| Dec 31, 2010 | 91,134.00 |